Efficacy of Sovateltide (PMZ-1620) in Patients of Acute Ischemic Stroke
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 158 participants.
Also called NCT04047563
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 158 participants
- Sponsor
- Registry
-
NCT04047563
-
- Other papers using this trial's data
- Efficacy and Safety of Sovateltide in Patients with Acute Cerebral Ischaemic Stroke: A Randomised, Double-Blind, Placebo-Controlled, Multicentre, Phase III Clinical Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- India
- Registry status
- Completed
Technical summary
Registry record NCT04047563. Randomized; quadruple masking; primary purpose treatment. Start 2019-11-10 (actual); primary completion 2022-02-10 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy of Sovateltide (PMZ-1620) in Patients of Acute Ischemic Stroke
- Condition
- Cerebral Ischemia
- Condition
- Cerebral Infarction
- Condition
- Stroke, Acute
- Intervention (Drug)
- Normal Saline along with standard treatment
- Intervention (Drug)
- PMZ-1620 (sovateltide) along with standard treatment
- Lead sponsor
- Pharmazz, Inc.
Record details
- Record id
cardio:ct-nct04047563- Content hash
fcc471c3ff286512b88359538e9ccf27506e6bb2568599258c54446fd7a3636b